Drawing for Serial No. 79293599

USPTO serial 79293599

Serial No. 79293599

Reviewed by CopyMark Law Group

Reg. 6648758Status 700Registered
Filing date
Status date
Registration date
Feb 22, 2022
Examiner
PEREZ, STEVEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79293599?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Adjuvants for medical purposes; cells for medical use; biological cell preparations for the treatment of diseases and disorders, namely, ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and stroke; pharmaceutical preparations for the prevention or treatment of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and strokeACTIVE
010Medical apparatus and instruments, namely, instruments and syringes for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, instruments and syringes for medical use for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; prosthetic tissues for parietal, visceral and vascular use; Medical apparatus and instruments, namely, syringes for medical purposes for injections for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, syringes for medical purposes for injections for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; eye testing machines and apparatus; Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; and Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instrumentsACTIVE
042Scientific and medical research and development in the field of cells; research and development of pharmaceuticals and medical apparatus and instruments for others; research and development services relating to medicines; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 16, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 27, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2022FIMPFINAL DISPOSITION PROCESSED
May 22, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2021GPNXNOTIFICATION PROCESSED BY IB
Dec 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2021XAECEXAMINER'S AMENDMENT ENTERED
Nov 3, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 3, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Nov 3, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
May 13, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 6, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 6, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 29, 2020RFNTREFUSAL PROCESSED BY IB
Nov 12, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 12, 2020RFRRREFUSAL PROCESSED BY MPU
Oct 23, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 22, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2020DOCKASSIGNED TO EXAMINER
Sep 22, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Sep 18, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance